Motorcar Parts of America, Inc. — Form 10-Q Summary
Business Context and Reporting Period
MPA supplies remanufactured and replacement automotive parts, including rotating electrical, wheel hub, brake-related and other products, as well as automotive testing and diagnostic equipment. The filing covers the three and six months ended September 30, 2022, the second quarter and first half of fiscal 2023. Financial statements are unaudited.
Key Financial Metrics
| Metric | Three Months Ended Sept. 30, 2022 | Prior Year | Six Months Ended Sept. 30, 2022 | Prior Year |
|---|---|---|---|---|
| Net sales | $172.5 million | $175.5 million | $336.5 million | $324.6 million |
| Gross profit | $26.5 million | $36.0 million | $56.8 million | $59.5 million |
| Gross margin | 15.4% | 20.5% | 16.9% | 18.3% |
| Operating income | $1.9 million | $9.6 million | $9.2 million | $15.3 million |
| Net income (loss) | $(6.5) million | $3.7 million | $(6.7) million | $4.5 million |
| Diluted EPS | $(0.34) | $0.19 | $(0.35) | $0.23 |
| Cash flow from operations | $(16.0) million | $(19.6) million | $(17.0) million | $(24.3) million |
At September 30, 2022, cash and cash equivalents were $7.6 million, short-term investments were $2.0 million, working capital was $114.5 million and total assets were $1.015 billion. Inventory was $401.2 million, including a $15.7 million increase from March 31, 2022, primarily to address supply-chain disruptions and anticipated demand.
Revolving debt was $163.0 million and term-loan principal was $15.0 million. The company had $69.3 million available under its revolving facility after contractual adjustments, plus $6.4 million of outstanding letters of credit. Total lease liabilities were $90.2 million. Receivables discounted during the six-month period totaled $283.4 million, with $11.3 million of related interest expense.
Material Changes Versus the Prior Comparable Period
- Second-quarter sales decreased 1.7%, although management reported a 6.6% increase excluding $13.7 million of prior-year core revenue related to a customer distribution-center inventory realignment. First-half sales increased 3.7%, or 8.3% excluding that prior-year item.
- Gross margin declined 510 basis points in the quarter and 140 basis points year to date. Management cited inflation, freight and logistics costs, higher wages, product mix, supply shortages affecting diagnostic and heavy-duty products, and the absence of the prior-year inventory realignment benefit.
- Quarterly operating income fell to $1.9 million from $9.6 million, while net income shifted to a loss of $6.5 million. Higher interest expense was a major factor: quarterly interest expense increased 156% to $9.3 million, and first-half interest expense increased 114% to $16.2 million.
- First-half operating cash usage improved to $17.0 million from $24.3 million, but the company ended the period with a $15.4 million decrease in cash after investing, financing and foreign-exchange effects.
- Foreign-exchange expense was $1.1 million in the quarter and $1.8 million year to date. General and administrative, sales and marketing, and research and development expenses all increased year over year for the first half.
Outlook, Commentary, Risks and Unusual Items
- Management expects certain price increases implemented at the end of the quarter to benefit gross margin. A customer’s inventory-reduction initiatives are expected to reverse in the second half of fiscal 2023.
- Management expects approximately $6.2 million of fiscal 2023 capital expenditures, primarily for current operations and growth initiatives. No formal revenue or earnings guidance is provided in the filing.
- COVID-19, global supply-chain and logistics disruptions remain risks. Reported COVID-related costs were $0.8 million in the quarter and $1.5 million for the first half, compared with $1.0 million and $1.8 million, respectively, in the prior-year periods.
- On November 3, 2022, the company amended its credit facility. The amendment modified certain fixed-charge and senior-leverage covenants, revised the definition of Consolidated EBITDA, and replaced LIBOR with a SOFR-based benchmark. The covenant changes were effective as of September 30, 2022. The company reported compliance, with a senior leverage ratio of 3.19 versus a maximum of 3.25 and fixed-charge coverage of 1.04 versus a minimum of 1.01.
- The company faces a potential claim from U.S. Customs and Border Protection for approximately $17 million of additional duties relating to imports from Mexico during 2011 through mid-2018. MPA disputes the amount and intends to defend the matter; the filing states that future accrual or payment cannot be assured.
- Customer concentration is significant: three customers represented 85% of quarterly sales and 83% of first-half sales. The company also depends on receivable-discount programs that may not continue and whose costs rise with interest rates or extended collection periods.
- No shares were repurchased during the quarter. As of September 30, 2022, $18.3 million remained available under the authorized repurchase program, subject to credit-facility restrictions.
Important Facts for Investors to Verify
- Whether price increases offset inflation, freight, labor and supply-chain costs and restore gross margins.
- The pace of inventory reduction or conversion into sales and operating cash flow.
- Interest-rate exposure, receivable-discount utilization and availability under the revolving facility.
- Continued compliance with the amended credit covenants and the effect of the SOFR transition.
- Resolution and potential financial impact of the approximately $17 million customs-duty dispute.
- Customer concentration, the expected reversal of customer inventory reductions, and sustainability of growth in brake-related and electric-vehicle testing products.